Anti-Smoking Legislation Underpins Nicotine Addiction Therapy Market

Report this content

The increasing emergence of smokeless electronic ‘e-cigarette’ products have split opinion as effective treatments

ReportBuyer.com the leading website for market research reports has added "Substance Abuse Therapeutics Market to 2018 - Effective Drug Therapies in the Treatment of Alcohol and Opioid Dependence Offer Significant Market Opportunities" which argues that the effectiveness of current pharmaceutical treatments depends as much on enforced legislation, such as smoking bans, and support from healthcare providers as an individual’s willingness to quit.

Anti-smoking legislation and structured support from healthcare providers is essential to achieve widespread smoking cessation says the 97 page report.

According to the World Health Organization (WHO), up to half of all ‘lifelong’ tobacco users will die from a tobacco-related disease, while the five million deaths that occur as a result of smoking every year outnumber the collective lives lost to HIV/AIDS, malaria and tuberculosis. Nicotine addiction therefore represents a serious public health risk and must be met with effective cessation therapies.

The prevalent population for nicotine addiction stood at 136.7 million in 2011, while the ‘diagnosed’ population, defined as those going to visit a physician concerning smoking cessation, was only 40 million. Furthermore, GlaxoSmithKline claims that while 70% of smokers want to quit less than 5% actually do, indicating a massive opportunity for companies willing to enter the market.

Popular Nicotine Replacement Therapies (NRTs) are conveniently available over-the-counter and account for 75% of all smoking cessation therapies sold worldwide, with patches, gum, lozenges, sprays and inhalers available to deliver doses of nicotine and reduce the effects of withdrawal.

The increasing emergence of smokeless electronic ‘e-cigarette’ products have split opinion as effective treatments as, while e-cigarettes are often marketed as anti-smoking treatments, they are often sponsored by large tobacco companies and arguably serve to keep smokers addicted. Furthermore, the ‘e-cigarette’ market is currently unregulated, while low-grade nicotine is often used, which may have unpleasant and possibly dangerous side-effects.

Code: GBI00454

http://www.reportbuyer.com/pharma_healthcare/therapeutic/substance_abuse_therapeutics_market_2018.html

press@reportbuyer.com

44 (0) 20 7060 7474

Reportbuyer.com is the online store for global business information. The website now lists more than 200,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.

Tags: